Neither soyfoods nor isoflavones warrant classification as endocrine disruptors: a technical review of the observational and clinical data
Mark Messina, Sonia Blanco Mejía, Aedín Cassidy, Alison M. Duncan, Mindy S. Kurzer, Chisato Nagato, Martin J. J. Ronis, Ian Rowland, John L. Sievenpiper, Stephen Barnes
Abstract
isoflavone exposure, but the existing data are reassuring. Adverse effects of isoflavone intake were not identified in children, but limited research has been conducted. After extensive review, the evidence does not support classifying isoflavones as endocrine disruptors.
Topics & Concepts
PhytoestrogensIsoflavonesMedicineObservational studyEndocrine systemAdverse effectPhysiologyEstrogenBioinformaticsInternal medicineBiologyHormonePhytoestrogen effects and researchBreastfeeding Practices and InfluencesCancer Risks and Factors